Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

NCT06390410 is registered in ClinicalTrials.gov with Cassava Sciences, Inc. as lead sponsor.

NCT NCT06390410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06390410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function
Lead sponsor
Cassava Sciences, Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 26, 2024
Completion date
December 7, 2024
Enrollment
27 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic insufficiency